Xcelience Expands GMP Manufacturing Capabilities Offering Small Scale Batch Production for Companies with Limited API

(Tampa, FL; January 27, 2009) – Xcelience, a leader in early drug development services, recently expanded their GMP manufacturing capabilities with the purchase of three new pieces of equipment offering a solution to pharmaceutical companies facing the challenges of limited API.

"Xcelience is proud to be a service provider that will go the extra mile for our clients,” stated Xcelience President and CEO, Derek G. Hennecke. “Our commitment to quality, decades of drug development experience, and state-of-the-art equipment combine to accelerate drug development programs and meet critical product and financial milestones.”

“The purchase of the low-volume feeder, the Diosna P1-6 High Shear Granulator, and the Vector LD CS results in the added capability of small batch production to meet customer needs in cases where API is limited. This addition represents our continued commitment to provide cutting edge equipment appropriately scaled to the needs of our clients, and to deliver solutions that save time and money, without compromising quality,” stated Director of Operations, Ted Koontz.

Xcelience, LLC, has an established history of adopting innovative technology in response to client needs and quickly building industry-leading expertise. Xcelience was the first CRO in North America to implement the patented Xcelodose® 600 Precision Micro-Filling System encapsulator which fills API directly to capsules, and one of the first CROs to implement the new Xcelodose® 600 S series (Xcelodose® is a registered trademark of Capsugel® BVBA). Xcelience recently enhanced preformulation services with the purchase of XRD (x-ray diffraction) instrumentation and expanded packaging capabilities to include a TF1 Blister Packaging Thermoformer machine.

Xcelience, LLC, is an early development contract research organization focused on formulation development, preformulation services, analytical services, and clinical trial manufacturing. The company has earned a solid reputation of accelerating early development activities to speed potential drugs to clinical trials while applying unparalleled scientific knowledge and experience.

About Xcelience
Xcelience, LLC, is your premier source for formulation development and manufacturing solutions. From preformulation to clinical supplies manufacturing and stability, we have one focus: the success of your project. Our state-of-the-art equipment, combined with years of experience providing innovative solutions, make the path from compound to clinic feel effortless. Visit www.xcelience.com.